| PRD_002484 | Name: | [(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing BGC and ADE) | Definition date: | 2023-06-14 | Last modified: | 2023-06-14 |
|
| PRD_001065 | Name: | teicoplanin | Formula: | C88 H97 Cl2 N9 O34 | Definition date: | 2013-05-29 | Last modified: | 2023-06-11 |
|
| PRD_002099 | Name: | Uridine 5'Diphospho N-acetyl muramoyl-L-Alanyl-D-Glutamyl-L-Lysine | Formula: | C34 H55 N7 O24 P2 | Definition date: | 2013-10-02 | Last modified: | 2023-06-11 |
|
| PRD_002268 | Name: | Lipid II | Formula: | C54 H91 N8 O26 P2 | Definition date: | 2020-08-19 | Last modified: | 2023-06-11 |
|
| PRD_002353 | Name: | Blood group B type 1 antigen, beta anomer | Formula: | C26 H45 N O20 | Definition date: | 2022-03-02 | Last modified: | 2023-06-11 |
|
| PRD_002512 | Name: | all-D Helicon Polypeptide FP40914 | Formula: | C92 H114 N20 O22 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
| PRD_002513 | Name: | all-D Helicon Polypeptide FP40926 | Formula: | C86 H116 N22 O24 S3 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
| PRD_002514 | Name: | an all-D Helicon Polypeptide FP40927 | Formula: | C81 H122 N19 O21 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
| PRD_002515 | Name: | all-D Helicon Polypeptide FP40918 | Formula: | C84 H115 N22 O26 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
| PRD_002471 | Name: | N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-carbamimidamido-2-oxohexan-3-yl]-L-phenylalaninamide | Formula: | C31 H40 N6 O5 | Definition date: | 2022-10-12 | Last modified: | 2022-10-12 |
|
| PRD_002472 | Name: | N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-(carbamoylamino)-2-oxohexan-3-yl]-L-phenylalaninamide | Formula: | C31 H39 N5 O6 | Definition date: | 2022-10-12 | Last modified: | 2022-10-12 |
|
| PRD_002496 | Name: | evybactin | Formula: | C64 H91 N21 O21 | Definition date: | 2022-08-17 | Last modified: | 2022-08-17 |
|
| PRD_000468 | Name: | Allosamidin | Formula: | C25 H42 N4 O14 | Definition date: | 2015-07-18 | Last modified: | 2022-03-03 |
|
| PRD_000323 | Name: | (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-[(1S,2R,3R)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-N~4~-[2-(d
imethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenylethyl]butanediamide | Formula: | C34 H53 N5 O5 S | Definition date: | 2012-12-12 | Last modified: | 2022-03-02 |
|
| PRD_000204 | Name: | Vancomycin | Formula: | C66 H75 Cl2 N9 O24 | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | Definition date: | 2012-12-12 | Last modified: | 2022-01-06 |
|
| PRD_002455 | Name: | D-PMI-omega | Formula: | C82 H115 Cl N17 O20 | Definition date: | 2021-11-17 | Last modified: | 2021-11-17 |
|
| PRD_002459 | Name: | dodecyl 6-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside | Formula: | C24 H46 O11 | Definition date: | 2021-08-04 | Last modified: | 2021-08-04 |
|
| PRD_002457 | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | Formula: | C18 H31 F O15 | Definition date: | 2021-05-19 | Last modified: | 2021-05-19 |
|
| PRD_002449 | Name: | (ACE)(1MH)D(B3L)F(1U8) | Formula: | C44 H54 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002450 | Name: | (ACE)(1MH)D(PF5)F(1U8) | Formula: | C46 H45 F5 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
| PRD_900106 | Name: | 6-S-alpha-D-mannopyranosyl-6-thio-alpha-D-mannopyranose | Formula: | C12 H22 O10 S | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | Definition date: | 2020-07-29 | Last modified: | 2020-08-05 |
|
| PRD_900001 | Name: | MALTOSE | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900002 | Name: | raffinose | Formula: | C18 H32 O16 | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_900003 | Name: | SUCROSE | Formula: | C12 H22 O11 | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|